News Conference News NY Valves 2024 Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli Michael O'Riordan June 05, 2024
News Conference News EuroPCR 2024 TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis Michael O'Riordan May 16, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News EuroPCR 2024 Debate Continues on TAVI Choice for Women With Small Annuli Yael L. Maxwell May 14, 2024
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024
News Daily News Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift Yael L. Maxwell May 03, 2024
News Conference News ACC 2024 SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve L.A. McKeown April 07, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2023 Shelley Wood November 30, 2023
News Daily News Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO Todd Neale November 29, 2023
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Conference News TCT 2023 VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli L.A. McKeown October 27, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
Presentation TCT 2023 Four-Year Outcomes From the EVOLUT Low Risk Trial Presenter: Michael Reardon October 24, 2023
News Daily News SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry Yael L. Maxwell October 20, 2023